Richard V Panetta, APRN | |
Np Resources, Llc., Six Coprporate Drive, Suite 420, Shelton, CT 06484 | |
(203) 925-9600 | |
(203) 926-0594 |
Full Name | Richard V Panetta |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | Np Resources, Llc., Shelton, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104829720 | NPI | - | NPPES |
004195865 | Medicaid | CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LG0600X | Nurse Practitioner - Gerontology | 002011 (Connecticut) | Primary |
363L00000X | Nurse Practitioner | 002011 (Connecticut) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Richard V Panetta, APRN 95 Marney Dr, Middlebury, CT 06762-2024 Ph: (203) 758-8350 | Richard V Panetta, APRN Np Resources, Llc., Six Coprporate Drive, Suite 420, Shelton, CT 06484 Ph: (203) 925-9600 |
News Archive
An international research team has identified what may be a critical molecule in the ability of tumours to metastasize - or spread - into bone.
Angiotension-converting enzyme (ACE) inhibitors, medications commonly used to treat hypertension (high blood pressure), may reduce cardiovascular risk and the risk of death in patients with coronary artery disease, according to a new analysis of previously conducted clinical trials reported in the Archives of Internal Medicine.
An Ohio Federal Court of Appeals ruling issued yesterday is reinstating the late victim's claim that the recalled diet drug Redux (commonly called fen-phen) linked to her death should never have been marketed to the American people by Wyeth due in part to its pre-approval concerns about potentially lethal side effects.
Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation.
The targeted drug nivolumab significantly prolongs survival in patients with advanced kidney cancer, whose disease has progressed after their first treatment, according to results to be presented at the 2015 European Cancer Congress today (Saturday) and published simultaneously in the New England Journal of Medicine.
› Verified 5 days ago
Susan Penque, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 18 Frans Way, Shelton, CT 06484 Phone: 516-640-6195 | |
Jacqueline Aileen Gambeski, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4 Corporate Dr Ste 290, Shelton, CT 06484 Phone: 203-452-8322 | |
Dolores Starrett, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7 Acadia Ln Unit 6103, Shelton, CT 06484 Phone: 203-808-5509 | |
Mrs. Elyane L Michnick, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6 Corporate Dr, Suite 420, Shelton, CT 06484 Phone: 203-925-9600 Fax: 203-926-0594 | |
Marie Oge-nerette, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15 Cranston Ave, Shelton, CT 06484 Phone: 203-209-4837 | |
Nina Marie Lamagna, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 Progress Drive Suite 200, Np Care Llc, Shelton, CT 06484 Phone: 203-925-9600 | |
Mrs. Kaitlyn Finneran, DNP, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 110 Commerce Dr, Shelton, CT 06484 Phone: 203-308-6914 |